Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT00595257

Feasability Study of Autologous Bone Marrow Aspirate Concentrate for Treatment of CLI

Feasibility Study of the Safety and Activity of Autologous Bone Marrow Aspirate Concentrate (BMAC) for the Treatment of Non Reconstructable Critical Limb Ischemia Due to Peripheral Arterial Occlusive Disease

Sponsor: Harvest Technologies

Conditions Arterial Occlusive Diseases

Interventions centrifuge, laboratory, tabletop (SmartPReP2 BMAC System)

Updated 5 times since 2017 Last updated: Mar 8, 2012 Started: Dec 31, 2007 Primary completion: Oct 31, 2009 Completion: Apr 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Arterial Occlusive Diseases and is currently completed. Harvest Technologies leads this study, which shows 5 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Dec 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Harvest Technologies

Data source: Harvest Technologies

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Porur, India